Contemporary European practice in left atrial appendage closure: results from a survey focusing on planning, techniques and post-implantation management
The present survey indicates that LAAC has become a widespread procedure in Europe. The findings highlight considerable heterogeneity among European countries in terms of preprocedural planning, procedural techniques including guidance and the post-procedural antithrombotic regimen. There is a need to evaluate the outcomes of different practices.
Authors
- Ole De Backer (ORCID: https://orcid.org/0000-0002-9674-0278)
- Sergio Berti
- Adel Aminian (ORCID: https://orcid.org/0000-0002-4667-9181)
- Xavier Freixa (ORCID: https://orcid.org/0000-0002-3203-9060)
- Nina Ajmone Marsan (ORCID: https://orcid.org/0000-0001-7208-5769)
- Philippe Garot (ORCID: https://orcid.org/0009-0001-8960-7006)
- Ignacio Cruz‐González (ORCID: https://orcid.org/0000-0001-9742-6072)
- Lorenz Räber
- Jens-Erik Nielsen-Kudsk
Institutions
- University Hospital of Bern (CH)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
- Technische Universität Darmstadt (DE)
- Complejo Hospitalario de Salamanca (ES)
- Klinikum Darmstadt (DE)
- Hospital Clínic de Barcelona (ES)
- Hôpital Privé Jacques Cartier (FR)
- Grand Charleroi Hospital (BE)
- Fondazione Toscana Gabriele Monasterio (IT)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-090541
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- Amgen
- AstraZeneca
- Sanofi
- Boston Scientific Corporation
- Regeneron Pharmaceuticals
- InfraRedx
- Novo Nordisk